Status:
COMPLETED
Acceptability of Long-term Progestin-only Contraception in Europe
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
20-35 years
Brief Summary
The study examines the use of Mirena or Implanon for long-term contraception in women. The duration of therapy use is the key focus of the study. Also, any reasons for discontinuation and the safety p...
Eligibility Criteria
Inclusion
- Women aged 20-35 in good general health requesting contraception
- Women who have used short-acting hormonal contraception (combined or progestogen-only pills, vaginal ring or contraceptive patch) for at least 3 cycles immediately before entering the study and opting to change to either Mirena or Implanon for contraception
- Women who have given a written informed consent to participate in the study (if applicable)
Exclusion
- The contraindications and warnings of the respective Summary of Product Characteristics (Mirena or Implanon) must be followed. The decision to start Mirena or Implanon has to be made clearly before the decision to include patients in the study
- Patients who are breast-feeding at time of inclusion for the study will also be excluded since breast-feeding affects the bleeding pattern
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
436 Patients enrolled
Trial Details
Trial ID
NCT00931827
Start Date
January 1 2008
End Date
November 1 2011
Last Update
December 24 2013
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Many Locations, France
2
Many Locations, Ireland
3
Many Locations, Slovakia
4
Many Locations, United Kingdom